Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Ninlaro in Real World Clinical Practice in China

NCT04328662

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Chao-yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hospital Beijing, Beijing Municipality, China
View all 28 locations
View Trial Details
Completed

An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma

NCT03601078

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • University Of California San Francisco Medical Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 25 locations
View Trial Details
Completed

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

NCT02833610

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts general Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
View Trial Details
Completed

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

NCT05804032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Universitätsklinikum Krems Krems, Austria
  • Ordensklinikum Linz Linz, Austria
  • Landeskrankenhaus Feldkirch-Rankweil Rankweil, Austria
  • Universitätsklinikum der Paracelsus, 3. Med. Abteilung/Onkologie Ambulanz Salzburg, Austria
View all 91 locations
View Trial Details
Completed

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

NCT05561751

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • University of Florida (UF) - Shands Cancer Center Gainesville, Florida, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

NCT05014412

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
  • Cancer Care & Hematology - Fort Collins Fort Collins, Colorado, United States
View all 50 locations
View Trial Details
Completed

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT04674813

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 005 Birmingham, Alabama, United States
  • Local Institution - 009 Duarte, California, United States
  • Local Institution - 012 San Francisco, California, United States
  • Local Institution - 002 Denver, Colorado, United States
View Trial Details
Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details

Related conditions